mitigating alzheimer's
Contact Us
The most worrisome aspect of Alzheimer’s is the notion that there is nothing to be done for the disease. This is no longer true. We are providers for the intervention that identifies and treats both those at risk for Alzheimer’s and those with early cognitive decline, giving peace of mind to them and to their families.
What’s New
Mitigating Alzheimer’s

About MD&T

Mindful Diagnostics and Therapeutics (MD&T) employs extensive laboratory testing and other features of the MEND protocol, the ReCODE protocol and the Bredesen protocol; all developed by Dr. Dale Bredesen, a neurologist and author of the book “The End of Alzheimer’s”. Additionally MD&T provides further testing and coaching focusing on Alzheimer’s risk and education …
resulting in a personalized  treatment program.

MD&T is intended for those who want to mitigate their risk of Alzheimer’s, those who carry genetic risk for Alzheimer’s (APOE4 gene and/or strong family history). Individuals who have been diagnosed with MCI (mild cognitive impairment) And those with early Alzheimer’s disease.

Why?
Why?

As Dr. Bredesen states in his book The End of Alzheimer’s — Alzheimer’s disease can be prevented and in many cases the symptoms can be reversed. We are so tainted by the lack of success in treating Alzheimer’s dementia that these bold words can only be viewed with skepticism. The science behind Mindful Diagnostics and Therapeutics suggests that a personalized program can prevent cognitive decline and, for those affected by early Alzheimer’s, MCI (mild cognitive impairment) and SCI (subjective cognitive impairment) can restore their ability to remember, to think and live a brain healthy life.

What?
What?
The elements of the program include blood testing to survey your body’s biochemical state as it relates to factors that support brain (neuronal and synaptic) health. It includes genetic analysis (via a “spit test”) by the popular company 23 AND ME. The metabolic and genetic information is processed by “big data” to create an action plan. Additionally, lifestyle changes known to support brain health are recommended and monitored: these include sleep, diet, exercise and stress reduction. A two-year program includes several interventions and corresponding adjustments to optimize the individual’s protocol and results.
Be in the moment
for yourself
your family
your friends
Be in the moment
for yourself
your family
your friends
Who?
Inclusion
Below is the list of inclusion/exclusion criteria.

Patients who experience or are diagnosed with any of the following are good candidates for the MEND Protocol:

  • Carry APOE4 gene
  • Diagnosis of Mild Cognitive Impairment (MCI)
  • Diagnosis of Alzheimer’s disease within the past five years
  • Progressive memory loss
  • SAGE score of 12 or higher (those with lower scores are unlikely to see improvement, but if the patient understands this and wishes to continue anyway, they may)
    • Exclusion
    Patients who experience or are diagnosed with any of the following are not candidates for the MEND Protocol:
  • Alcoholic
    —- Patient must be sober for at least 3 months

  • Any other neurological disease outside of MCI or Alzheimer’s disease
    —- EX: vascular dementia, Parkinson’s disease, frontal temporal dementia

  • BMI above 35
  • Cancer
    —- Both current and recurring

  • Current Lyme disease
  • Currently in an Alzheimer’s trial
  • History of major stroke, repeated strokes, recurring TIA’s, or speech impediment due to stroke
  • Smoking
  • Stage 4 or 5 of chronic kidney disease (using K/DOQI guidelines)
  • Uncontrolled blood pressure greater than 140/90 (must be medically controlled to enroll)
  • Uncontrolled seizures or on multiple medications to treat seizures
  • Major depression
    —- On 3 or more medications to treat
    —- In need of counceling more than once a month
    —- Currently having suicidal thoughts/ideations
    • Partnering with